Marco Bottelier

433 total citations
18 papers, 250 citations indexed

About

Marco Bottelier is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Marco Bottelier has authored 18 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 10 papers in Cognitive Neuroscience and 3 papers in Experimental and Cognitive Psychology. Recurrent topics in Marco Bottelier's work include Attention Deficit Hyperactivity Disorder (13 papers), Neural and Behavioral Psychology Studies (7 papers) and Functional Brain Connectivity Studies (6 papers). Marco Bottelier is often cited by papers focused on Attention Deficit Hyperactivity Disorder (13 papers), Neural and Behavioral Psychology Studies (7 papers) and Functional Brain Connectivity Studies (6 papers). Marco Bottelier collaborates with scholars based in Netherlands, United States and Belgium. Marco Bottelier's co-authors include Liesbeth Reneman, Anouk Schrantee, Michiel B. de Ruiter, Nanda Rommelse, Jan K. Buitelaar, J. J. Sandra Kooij, Alejandro Arias Vásquez, Pieter J. Hoekstra, Hilde M. Geurts and Ramón Lindauer and has published in prestigious journals such as Scientific Reports, JAMA Psychiatry and BMC Psychiatry.

In The Last Decade

Marco Bottelier

18 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Bottelier Netherlands 10 189 131 42 31 26 18 250
Thomas Villemonteix France 11 270 1.4× 248 1.9× 46 1.1× 34 1.1× 44 1.7× 25 352
Margaretha Dramsdahl Norway 6 188 1.0× 143 1.1× 27 0.6× 57 1.8× 19 0.7× 6 260
Zhao-Min Wu China 11 246 1.3× 211 1.6× 53 1.3× 57 1.8× 36 1.4× 28 331
Janneke Dammers Netherlands 8 280 1.5× 227 1.7× 61 1.5× 53 1.7× 35 1.3× 8 359
Josep Salavert Spain 10 191 1.0× 86 0.7× 92 2.2× 15 0.5× 12 0.5× 17 276
P. Prosperini Italy 10 232 1.2× 150 1.1× 77 1.8× 24 0.8× 11 0.4× 20 350
Nadia Barrett United Kingdom 8 268 1.4× 258 2.0× 47 1.1× 15 0.5× 31 1.2× 11 342
Maja Kobel Switzerland 6 239 1.3× 237 1.8× 22 0.5× 73 2.4× 28 1.1× 6 346
Grant Hanada United States 9 294 1.6× 364 2.8× 27 0.6× 15 0.5× 36 1.4× 16 416
Ning Ji China 9 224 1.2× 157 1.2× 35 0.8× 10 0.3× 44 1.7× 13 321

Countries citing papers authored by Marco Bottelier

Since Specialization
Citations

This map shows the geographic impact of Marco Bottelier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bottelier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bottelier more than expected).

Fields of papers citing papers by Marco Bottelier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Bottelier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bottelier. The network helps show where Marco Bottelier may publish in the future.

Co-authorship network of co-authors of Marco Bottelier

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Bottelier. A scholar is included among the top collaborators of Marco Bottelier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Bottelier. Marco Bottelier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Oosterlaan, Jaap, Pierre M. Bet, Marco Bottelier, et al.. (2024). Placebo-related improvement with methylphenidate treatment in children with ADHD. European Child & Adolescent Psychiatry. 34(3). 1161–1170. 2 indexed citations
2.
3.
Schrantee, Anouk, Marco Bottelier, J. J. Sandra Kooij, et al.. (2024). Prediction of methylphenidate treatment response for ADHD using conventional and radiomics T1 and DTI features: Secondary analysis of a randomized clinical trial. NeuroImage Clinical. 45. 103707–103707. 1 indexed citations
4.
Luman, Marjolein, James M. Swanson, Marco Bottelier, et al.. (2023). Methylphenidate dose–response in children with ADHD: evidence from a double-blind, randomized placebo-controlled titration trial. European Child & Adolescent Psychiatry. 33(2). 495–504. 9 indexed citations
5.
Reneman, Liesbeth, et al.. (2021). Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD. European Neuropsychopharmacology. 46. 1–13. 16 indexed citations
6.
Bottelier, Marco, Michiel B. de Ruiter, Hilde M. Geurts, et al.. (2021). Effects of prolonged methylphenidate treatment on amygdala reactivity and connectivity: a randomized controlled trial in stimulant treatment-naive, male participants with ADHD. PubMed. 1(3). 152–163. 1 indexed citations
7.
Schrantee, Anouk, Marco Bottelier, Paul J. Lucassen, et al.. (2020). Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Frontiers in Psychiatry. 11. 82–82. 14 indexed citations
8.
Stikkelbroek, Yvonne, Gerko Vink, Maaike H. Nauta, et al.. (2020). Effectiveness and moderators of individual cognitive behavioral therapy versus treatment as usual in clinically depressed adolescents: a randomized controlled trial. Scientific Reports. 10(1). 14815–14815. 10 indexed citations
9.
Bottelier, Marco, et al.. (2017). Elimination diets’ efficacy and mechanisms in attention deficit hyperactivity disorder and autism spectrum disorder. European Child & Adolescent Psychiatry. 26(9). 1067–1079. 50 indexed citations
10.
Caan, Matthan W.A., Anouk Schrantee, Marco Bottelier, et al.. (2017). ADHD and maturation of brain white matter: A DTI study in medication naive children and adults. NeuroImage Clinical. 17. 53–59. 38 indexed citations
11.
Schrantee, Anouk, Esther E. Bron, Stefan Klein, et al.. (2017). Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging and Behavior. 12(2). 402–410. 9 indexed citations
12.
Bottelier, Marco, Anouk Schrantee, B. Ferguson, et al.. (2017). Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Research Neuroimaging. 269. 36–42. 14 indexed citations
13.
Schrantee, Anouk, Marco Bottelier, Paul J. Lucassen, et al.. (2017). Enduring effects of methylphenidate on sleep in children with attention-deficit/hyperactivity disorder: a double-blind randomized controlled trial. European Neuropsychopharmacology. 27. S1111–S1112. 2 indexed citations
14.
Schrantee, Anouk, Marco Bottelier, Esther E. Bron, et al.. (2016). Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder. JAMA Psychiatry. 73(9). 955–955. 50 indexed citations
15.
Bottelier, Marco, Anouk Schrantee, Guido van Wingen, et al.. (2016). A power analysis for future clinical trials on the potential adverse effects of SSRIs on amygdala reactivity. Frontiers in Biology. 11(3). 256–259. 1 indexed citations
16.
Bottelier, Marco, et al.. (2015). Effects of methylphenidate during emotional processing in amphetamine users: preliminary findings. Brain Imaging and Behavior. 9(4). 878–886. 9 indexed citations
17.
Bottelier, Marco, et al.. (2015). P.2.h.014 Treatment with fluoxetine in adolescents may aggravate emotional dysregulation: a power analysis for future studies. European Neuropsychopharmacology. 25. S461–S462. 1 indexed citations
18.
Bottelier, Marco, Anouk Schrantee, Michiel B. de Ruiter, et al.. (2014). The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. BMC Psychiatry. 14(1). 48–48. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Villemonteix Breakdown of academic impact, for papers by Margaretha Dramsdahl Breakdown of academic impact, for papers by Zhao-Min Wu Breakdown of academic impact, for papers by Janneke Dammers Breakdown of academic impact, for papers by Josep Salavert Breakdown of academic impact, for papers by P. Prosperini Breakdown of academic impact, for papers by Nadia Barrett Breakdown of academic impact, for papers by Maja Kobel Breakdown of academic impact, for papers by Grant Hanada Breakdown of academic impact, for papers by Ning Ji
Rankless by CCL
2026